123 related articles for article (PubMed ID: 7338557)
1. A pharmacokinetic and pharmacodynamic assessment of a combined slow-release metoprolol-chlorthalidone preparation.
Kendall MJ; Lambert L; Quarterman CP; John VA
J Clin Hosp Pharm; 1981 Dec; 6(4):259-65. PubMed ID: 7338557
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
Godbillon J; Gerardin A; John VA; Theobald W
Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
[TBL] [Abstract][Full Text] [Related]
3. [Echocardiographic changes in hypertensive patients treated with a fixed combination of metoprolol and chlorthalidone].
Vincenzi M; De Dominicis E; Lazzaretto R; Mattiello M; Onza I
Minerva Cardioangiol; 1986 Oct; 34(10):625-31. PubMed ID: 3808330
[No Abstract] [Full Text] [Related]
4. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
[TBL] [Abstract][Full Text] [Related]
5. A fixed combination of metoprolol slow-release and chlorthalidone, given once daily, in the long-term treatment of arterial hypertension.
Floris B; Franchetta G; Palestini N; Sonaglioni G; Verdecchia P; Bichisao E
J Int Med Res; 1982; 10(2):82-6. PubMed ID: 6802690
[TBL] [Abstract][Full Text] [Related]
6. Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone.
Kieso HA; Gould BA; Mann S; Hornung RS; Altman DG; Raftery EB
Br Med J (Clin Res Ed); 1983 Sep; 287(6394):717-20. PubMed ID: 6412795
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone (author's transl)].
Arndts D; Doevendans J; Arendt G; Rippen G
Arzneimittelforschung; 1981; 31(11):1954-7. PubMed ID: 7198476
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.
Jordö L; Johnsson G; Lundborg P; Persson BA; Regärdh CG; Rönn O
Br J Clin Pharmacol; 1979 Jun; 7(6):563-7. PubMed ID: 465277
[TBL] [Abstract][Full Text] [Related]
9. A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice.
Govind U; Munro BF; Robertson LI
S Afr Med J; 1981 Dec; 60(24):921-4. PubMed ID: 7029740
[TBL] [Abstract][Full Text] [Related]
10. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.
Folgering H; van Bussel M
Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241
[TBL] [Abstract][Full Text] [Related]
11. Chlorthalidone alone or in fixed combination with slow-release metoprolol in the management of arterial hypertension: a long-term study of 545 patients.
Bichisao E; Merlini L; Gambini O; Alberti D; Pollavini G
J Int Med Res; 1989; 17(4):339-49. PubMed ID: 2676651
[TBL] [Abstract][Full Text] [Related]
12. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1977 Nov; 14(5):321-48. PubMed ID: 201441
[TBL] [Abstract][Full Text] [Related]
13. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.
Kendall MJ; John VA; Quarterman CP; Welling PG
Eur J Clin Pharmacol; 1980 Feb; 17(2):87-92. PubMed ID: 7371709
[TBL] [Abstract][Full Text] [Related]
14. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic comparison between different slow-release formulations of metoprolol (Lopresor SR and Betaloc SA).
Browning RC; John VA; Till RJ; Theobald W
Br J Clin Pharmacol; 1981 Oct; 12(4):600-2. PubMed ID: 7295497
[No Abstract] [Full Text] [Related]
16. [Controlled study of the antihypertensive effects of the combination of metoprolol and chlorthalidone].
Albertazzi A; Del Rosso G; Cappelli P
G Clin Med; 1983; 64(3-4):124-30. PubMed ID: 6884639
[No Abstract] [Full Text] [Related]
17. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
18. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
Folgering HT; Borm JF; van Haaren RH
Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the antihypertensive effectiveness of the combination of metoprolol and chlorthalidone, using the ergometric test].
Matteoli S; De Martino A; Filabozzi P; Greco V; Manzi M; Simonetti BM; Cinotti GA; Stirati G
Boll Soc Ital Cardiol; 1981; 26(10):1207-11. PubMed ID: 7349142
[No Abstract] [Full Text] [Related]
20. Metoprolol with and without chlorthalidone in hypertension.
Kubik M; Kendall M; Ebbutt A; John V
Clin Pharmacol Ther; 1979 Jan; 25(1):25-32. PubMed ID: 363333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
